ArticleThe journal of allergy and clinical immunology. Global2026
Birch rust allergy as a novel autumnal trigger of seasonal airway symptoms.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fungi in Asthma: From Epidemiology and Airway Mycobiome to Molecular Mechanisms and Novel Allergenic Phytopathogens.International journal of molecular sciences · 2026Review
- Birch Rust Spore Exposure and Upper Airway Symptom Dynamics in a Subarctic Region: Indications for a Novel Seasonal Allergen.Clinical and translational allergy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate identification of allergenic triggers is essential for diagnosis, prevention, and management of airway allergies. In Tromsø (in northern Norway), birch rust (BR) spores are released in large quantities during autumn, a period with minimal dispersal of other environmental aeroallergens. This seasonal spike in BR spores coincides with an increase in symptoms of conjunctivitis, rhinitis, and asthma. Objective: Our aim was to investigate whether exposure to BR spores is associated with allergic airway symptoms in autumn. Methods: A total of 31 patients and 17 controls residing in Tromsø used a visual analog score to record their daily airway allergy symptoms from August 4 to October 14, 2020. Levels of specific IgE against BR and other relevant aeroallergens were measured in 13 patients and 7 controls. Skin prick testing for BR was conducted in 5 patients and 2 controls. Because of the lack of commercial reagents, test extracts from sampled BR spores were developed and produced during the study period. Airborne spore and pollen counts were collected from a monitoring station in Tromsø. Results: The mean symptom visual analog scale scores were significantly higher in the patients than in the controls. Of the 13 patients tested, 10 (76.9%) demonstrated specific IgE reactivity to BR spores. All 5 patients undergoing skin prick testing showed positive reactions to BR extracts. Conclusions: These findings suggest that BR spores may represent previously unrecognized aeroallergens contributing to seasonal allergic airway symptoms in autumn. Further studies are needed to validate these preliminary observations and to clarify the underlying nature of this allergy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.